RR Donnelley (RRD) Tops Q1 EPS by 4c
Tweet
Share
E-mail
Get Alerts RRD Hot Sheet
Price: $10.84 --0%
Financial Fact:
Restructuring and impairment charges-net (Note 6): 15M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Restructuring and impairment charges-net (Note 6): 15M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
RR Donnelley (NASDAQ: RRD) reported Q1 EPS of $0.22, $0.04 better than the analyst estimate of $0.18. Revenue for the quarter came in at $2.7 billion versus the consensus estimate of $2.62 billion.
The Company reiterates the following full-year guidance for 2016, which remains unchanged from previous guidance and excludes the impact of the previously announced pending spin-off transactions:
| Current Guidance | |
| Net sales | $11.3 to $11.5 billion |
| Non-GAAP adjusted EBITDA margin | 10.4% to 10.6% |
| Depreciation and amortization | $430 to $440 million |
| Interest expense | $260 to $270 million |
| Non-GAAP effective tax rate | 34% to 35% |
| Diluted share count | Approximately 211 million |
| Capital expenditures | $200 to $225 million |
| Free cash flow(1) | $400 to $500 million |
(1) Defined as operating cash flow less capital expenditures
For earnings history and earnings-related data on RR Donnelley (RRD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Keefe, Bruyette & Woods Downgrades Crescent BDC (CCAP) to Market Perform
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
